APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals for Diagnosis

Compare research editions
View pricing & licenses

Selected research

Industry Research

Radiopharmaceuticals for Diagnosis Industry Research Report 2026

27 December 2025132 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals for Diagnosis Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals for Diagnosis Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals for Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals for Diagnosis Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals for Diagnosis Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Radiopharmaceuticals for Diagnosis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Radiopharmaceuticals for Diagnosis is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceuticals for Diagnosis is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Radiopharmaceuticals for Diagnosis include Atom High-tech Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Tianjin Said Biopharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. and Guangdong Xi'ai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Radiopharmaceuticals for Diagnosis market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Radiopharmaceuticals for Diagnosis Market by Company

Atom High-tech Co., Ltd.

Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory

Tianjin Said Biopharmaceutical Co., Ltd.

Shenzhen Larven Bioengineering Technology Co., Ltd.

Shanghai Atom Kexing Pharmaceutical Co., Ltd.

Shanghai Xinke Pharmaceutical Co., Ltd.

Ningbo Jun'an Pharmaceutical Technology Co., Ltd.

Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.

Guangdong Xi'ai Pharmaceutical Co., Ltd.

Chengdu Zhonghe Gaotong Isotope Co., Ltd.

Chengdu Yunke Pharmaceutical Co., Ltd.

Chengdu Xinke Pharmaceutical Co., Ltd.

Beijing Zhibo High-tech Biotechnology Co., Ltd.

RadioMedix, Inc.

PDRadiopharma Inc.

Lantheus

Jubilant Radiopharma

GE Healthcare Ltd

DOE IP

Radiopharmaceuticals for Diagnosis Segment by Type

Strontium [89Sr] Chloride

Sodium Iodide [131I]

Iodine [125I] Sealed Seed Source

Technetium [99mTc] Pentetate

Technetium [99mTc] Polymerized Albumin

Technetium [99mTc] Dithiodithiocarbamate

Other

Radiopharmaceuticals for Diagnosis Segment by Application

Hospital

Clinic

Other

Radiopharmaceuticals for Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Radiopharmaceuticals for Diagnosis by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Radiopharmaceuticals for Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Radiopharmaceuticals for Diagnosis Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Radiopharmaceuticals for Diagnosis Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers (2021-2026) Table 8. Global Radiopharmaceuticals for Diagnosis Revenue of Manufacturers (2021-2026) Table 9. Global Radiopharmaceuticals for Diagnosis Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Radiopharmaceuticals for Diagnosis Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Radiopharmaceuticals for Diagnosis Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Radiopharmaceuticals for Diagnosis, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Radiopharmaceuticals for Diagnosis, Product Type & Application Table 14. Global Radiopharmaceuticals for Diagnosis Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Radiopharmaceuticals for Diagnosis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Atom High-tech Co., Ltd. Company Information Table 19. Atom High-tech Co., Ltd. Business Overview Table 20. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 22. Atom High-tech Co., Ltd. Recent Developments Table 23. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information Table 24. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview Table 25. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio Table 27. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments Table 28. Tianjin Said Biopharmaceutical Co., Ltd. Company Information Table 29. Tianjin Said Biopharmaceutical Co., Ltd. Business Overview Table 30. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 32. Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments Table 33. Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information Table 34. Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview Table 35. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 37. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments Table 38. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information Table 39. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview Table 40. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 42. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments Table 43. Shanghai Xinke Pharmaceutical Co., Ltd. Company Information Table 44. Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview Table 45. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 47. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments Table 48. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information Table 49. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview Table 50. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 52. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments Table 53. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information Table 54. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview Table 55. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 57. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments Table 58. Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information Table 59. Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview Table 60. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 62. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments Table 63. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information Table 64. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview Table 65. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 67. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments Table 68. Chengdu Yunke Pharmaceutical Co., Ltd. Company Information Table 69. Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview Table 70. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 72. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments Table 73. Chengdu Xinke Pharmaceutical Co., Ltd. Company Information Table 74. Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview Table 75. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 77. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments Table 78. Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information Table 79. Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview Table 80. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 82. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments Table 83. RadioMedix, Inc. Company Information Table 84. RadioMedix, Inc. Business Overview Table 85. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 87. RadioMedix, Inc. Recent Developments Table 88. PDRadiopharma Inc. Company Information Table 89. PDRadiopharma Inc. Business Overview Table 90. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 92. PDRadiopharma Inc. Recent Developments Table 93. Lantheus Company Information Table 94. Lantheus Business Overview Table 95. Lantheus Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio Table 97. Lantheus Recent Developments Table 98. Jubilant Radiopharma Company Information Table 99. Jubilant Radiopharma Business Overview Table 100. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio Table 102. Jubilant Radiopharma Recent Developments Table 103. GE Healthcare Ltd Company Information Table 104. GE Healthcare Ltd Business Overview Table 105. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio Table 107. GE Healthcare Ltd Recent Developments Table 108. DOE IP Company Information Table 109. DOE IP Business Overview Table 110. DOE IP Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio Table 112. DOE IP Recent Developments Table 113. Global Radiopharmaceuticals for Diagnosis Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026) & (K Units) Table 115. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2021-2026) Table 116. Global Radiopharmaceuticals for Diagnosis Sales by Region (2027-2032) & (K Units) Table 117. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2027-2032) Table 118. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2021-2026) Table 120. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2027-2032) Table 122. North America Radiopharmaceuticals for Diagnosis Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 124. North America Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 125. North America Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Radiopharmaceuticals for Diagnosis Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Radiopharmaceuticals for Diagnosis Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 129. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 130. Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Radiopharmaceuticals for Diagnosis Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Radiopharmaceuticals for Diagnosis Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Radiopharmaceuticals for Diagnosis Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 139. South America Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 140. South America Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Radiopharmaceuticals for Diagnosis Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 148. Global Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 149. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026) Table 150. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2027-2032) Table 151. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2026) Table 154. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2027-2032) Table 155. Global Radiopharmaceuticals for Diagnosis Price by Type (2021-2026) & (US$/Unit) Table 156. Global Radiopharmaceuticals for Diagnosis Price by Type (2027-2032) & (US$/Unit) Table 157. Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 158. Global Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 159. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026) Table 160. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2027-2032) Table 161. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2026) Table 164. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2027-2032) Table 165. Global Radiopharmaceuticals for Diagnosis Price by Application (2021-2026) & (US$/Unit) Table 166. Global Radiopharmaceuticals for Diagnosis Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Radiopharmaceuticals for Diagnosis Distributors List Table 170. Radiopharmaceuticals for Diagnosis Customers List Table 171. Radiopharmaceuticals for Diagnosis Industry Trends Table 172. Radiopharmaceuticals for Diagnosis Industry Drivers Table 173. Radiopharmaceuticals for Diagnosis Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Radiopharmaceuticals for Diagnosis Product Image Figure 5. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Radiopharmaceuticals for Diagnosis Market Size (2021-2032) & (US$ Million) Figure 7. Global Radiopharmaceuticals for Diagnosis Sales (2021-2032) & (K Units) Figure 8. Global Radiopharmaceuticals for Diagnosis Average Price (US$/Unit) & (2021-2032) Figure 9. Strontium [89Sr] Chloride Product Image Figure 10. Sodium Iodide [131I] Product Image Figure 11. Iodine [125I] Sealed Seed Source Product Image Figure 12. Technetium [99mTc] Pentetate Product Image Figure 13. Technetium [99mTc] Polymerized Albumin Product Image Figure 14. Technetium [99mTc] Dithiodithiocarbamate Product Image Figure 15. Other Product Image Figure 16. Hospital Product Image Figure 17. Clinic Product Image Figure 18. Other Product Image Figure 19. Global Radiopharmaceuticals for Diagnosis Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Radiopharmaceuticals for Diagnosis, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Radiopharmaceuticals for Diagnosis Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Radiopharmaceuticals for Diagnosis Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Radiopharmaceuticals for Diagnosis Sales by Region in 2025 Figure 25. Global Radiopharmaceuticals for Diagnosis Revenue by Region in 2025 Figure 26. North America Radiopharmaceuticals for Diagnosis Market Size by Country in 2025 Figure 27. North America Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 28. North America Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2032) Figure 29. United States Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Radiopharmaceuticals for Diagnosis Market Size by Country in 2025 Figure 33. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 34. Europe Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2032) Figure 35. Germany Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Radiopharmaceuticals for Diagnosis Market Size by Country in 2025 Figure 46. Asia Pacific Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2032) Figure 48. China Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Radiopharmaceuticals for Diagnosis Market Size by Country in 2025 Figure 57. South America Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 58. South America Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2032) Figure 59. Brazil Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country in 2025 Figure 63. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2032) Figure 65. Egypt Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Radiopharmaceuticals for Diagnosis Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2032) Figure 71. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2032) Figure 72. Global Radiopharmaceuticals for Diagnosis Price (US$/Unit) by Type (2021-2032) Figure 73. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2032) Figure 74. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2032) Figure 75. Global Radiopharmaceuticals for Diagnosis Price (US$/Unit) by Application (2021-2032) Figure 76. Radiopharmaceuticals for Diagnosis Value Chain Figure 77. Radiopharmaceuticals for Diagnosis Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges

Scope & coverage.

Types
  • Strontium [89Sr] Chloride
  • Sodium Iodide [131I]
  • Iodine [125I] Sealed Seed Source
  • Technetium [99mTc] Pentetate
  • Technetium [99mTc] Polymerized Albumin
  • Technetium [99mTc] Dithiodithiocarbamate
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Atom High-tech Co., Ltd.
  • Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  • Tianjin Said Biopharmaceutical Co., Ltd.
  • Shenzhen Larven Bioengineering Technology Co., Ltd.
  • Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  • Shanghai Xinke Pharmaceutical Co., Ltd.
  • Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  • Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  • Guangdong Xi'ai Pharmaceutical Co., Ltd.
  • Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  • Chengdu Yunke Pharmaceutical Co., Ltd.
  • Chengdu Xinke Pharmaceutical Co., Ltd.
  • Beijing Zhibo High-tech Biotechnology Co., Ltd.
  • RadioMedix, Inc.
  • PDRadiopharma Inc.
  • Lantheus
  • Jubilant Radiopharma
  • GE Healthcare Ltd
  • DOE IP

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Radiopharmaceuticals for Diagnosis Market Size (2021-2032)
  4. 2.2.2 Global Radiopharmaceuticals for Diagnosis Sales (2021-2032)
  5. 2.2.3 Global Radiopharmaceuticals for Diagnosis Market Average Price (2021-2032)
  6. 2.3 Radiopharmaceuticals for Diagnosis by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Strontium [89Sr] Chloride
  9. 2.3.3 Sodium Iodide [131I]
  10. 2.3.4 Iodine [125I] Sealed Seed Source
  11. 2.3.5 Technetium [99mTc] Pentetate
  12. 2.3.6 Technetium [99mTc] Polymerized Albumin
  13. 2.3.7 Technetium [99mTc] Dithiodithiocarbamate
  14. 2.3.8 Other
  15. 2.4 Radiopharmaceuticals for Diagnosis by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 Hospital
  18. 2.4.3 Clinic
  19. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Radiopharmaceuticals for Diagnosis Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Radiopharmaceuticals for Diagnosis Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Radiopharmaceuticals for Diagnosis Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Radiopharmaceuticals for Diagnosis Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Radiopharmaceuticals for Diagnosis Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Radiopharmaceuticals for Diagnosis, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Radiopharmaceuticals for Diagnosis, Product Type & Application
  8. 3.8 Global Manufacturers of Radiopharmaceuticals for Diagnosis, Established Date
  9. 3.9 Global Radiopharmaceuticals for Diagnosis Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Atom High-tech Co., Ltd.
  2. 4.1.1 Atom High-tech Co., Ltd. Company Information
  3. 4.1.2 Atom High-tech Co., Ltd. Business Overview
  4. 4.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  6. 4.1.5 Atom High-tech Co., Ltd. Recent Developments
  7. 4.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  8. 4.2.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
  9. 4.2.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
  10. 4.2.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio
  12. 4.2.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
  13. 4.3 Tianjin Said Biopharmaceutical Co., Ltd.
  14. 4.3.1 Tianjin Said Biopharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  18. 4.3.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Shenzhen Larven Bioengineering Technology Co., Ltd.
  20. 4.4.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
  21. 4.4.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
  22. 4.4.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  24. 4.4.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
  25. 4.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  26. 4.5.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  30. 4.5.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Shanghai Xinke Pharmaceutical Co., Ltd.
  32. 4.6.1 Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  36. 4.6.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  38. 4.7.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
  39. 4.7.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
  40. 4.7.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  42. 4.7.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
  43. 4.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  44. 4.8.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  48. 4.8.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Guangdong Xi'ai Pharmaceutical Co., Ltd.
  50. 4.9.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  54. 4.9.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  56. 4.10.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
  57. 4.10.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
  58. 4.10.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  60. 4.10.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
  61. 4.11 Chengdu Yunke Pharmaceutical Co., Ltd.
  62. 4.11.1 Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  66. 4.11.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Chengdu Xinke Pharmaceutical Co., Ltd.
  68. 4.12.1 Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  72. 4.12.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Beijing Zhibo High-tech Biotechnology Co., Ltd.
  74. 4.13.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
  75. 4.13.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
  76. 4.13.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  78. 4.13.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
  79. 4.14 RadioMedix, Inc.
  80. 4.14.1 RadioMedix, Inc. Company Information
  81. 4.14.2 RadioMedix, Inc. Business Overview
  82. 4.14.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  84. 4.14.5 RadioMedix, Inc. Recent Developments
  85. 4.15 PDRadiopharma Inc.
  86. 4.15.1 PDRadiopharma Inc. Company Information
  87. 4.15.2 PDRadiopharma Inc. Business Overview
  88. 4.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  90. 4.15.5 PDRadiopharma Inc. Recent Developments
  91. 4.16 Lantheus
  92. 4.16.1 Lantheus Company Information
  93. 4.16.2 Lantheus Business Overview
  94. 4.16.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio
  96. 4.16.5 Lantheus Recent Developments
  97. 4.17 Jubilant Radiopharma
  98. 4.17.1 Jubilant Radiopharma Company Information
  99. 4.17.2 Jubilant Radiopharma Business Overview
  100. 4.17.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio
  102. 4.17.5 Jubilant Radiopharma Recent Developments
  103. 4.18 GE Healthcare Ltd
  104. 4.18.1 GE Healthcare Ltd Company Information
  105. 4.18.2 GE Healthcare Ltd Business Overview
  106. 4.18.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio
  108. 4.18.5 GE Healthcare Ltd Recent Developments
  109. 4.19 DOE IP
  110. 4.19.1 DOE IP Company Information
  111. 4.19.2 DOE IP Business Overview
  112. 4.19.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio
  114. 4.19.5 DOE IP Recent Developments
5 Global Radiopharmaceuticals for Diagnosis Market Scenario by Region
  1. 5.1 Global Radiopharmaceuticals for Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021-2032
  3. 5.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021-2026
  4. 5.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2027-2032
  5. 5.3 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2021-2032
  6. 5.3.1 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2021-2026
  7. 5.3.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2027-2032
  8. 5.4 North America Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
  9. 5.4.1 North America Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  11. 5.4.3 North America Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
  16. 5.5.1 Europe Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  18. 5.5.3 Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
  41. 5.7.1 South America Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  43. 5.7.3 South America Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032)
  2. 6.1.1 Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2032)
  4. 6.2 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2032)
  5. 6.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Radiopharmaceuticals for Diagnosis Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032)
  2. 7.1.1 Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2032)
  4. 7.2 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2032)
  5. 7.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Radiopharmaceuticals for Diagnosis Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Radiopharmaceuticals for Diagnosis Value Chain Analysis
  2. 8.1.1 Radiopharmaceuticals for Diagnosis Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Radiopharmaceuticals for Diagnosis Production Mode & Process
  5. 8.2 Radiopharmaceuticals for Diagnosis Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Radiopharmaceuticals for Diagnosis Distributors
  8. 8.2.3 Radiopharmaceuticals for Diagnosis Customers
9 Global Radiopharmaceuticals for Diagnosis Analyzing Market Dynamics
  1. 9.1 Radiopharmaceuticals for Diagnosis Industry Trends
  2. 9.2 Radiopharmaceuticals for Diagnosis Industry Drivers
  3. 9.3 Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges
  4. 9.4 Radiopharmaceuticals for Diagnosis Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst